PTEN and endometrial cancer: Further investigation of genomic variations demonstrated high-frequency SNVs and CNVs in key regulators such as PTEN, ARID1A, and UBR4, particularly in endometrial cancer, where PTEN and ARID1A mutations were significantly enriched.